Differences were demonstrated between gliomas with and without IDH mutation, as transmigrated DCs exhibited delayed maturation due to the paracrine activity of 2-R-hydroxyglutarate in IDH-mutated gliomas, resulting in decreased expression of interleukin-6 and MHC-mediated antigen presentation. The gene discussed is HLA-C; the disease is central nervous system cancer.